Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Kiniksa Pharmaceuticals International Plc shares valued at $264,818 were sold by Ragosa Mark on Mar 17 ’25. At $23.10 per share, Ragosa Mark sold 11,464 shares. The insider’s holdings dropped to 23,382 shares worth approximately $0.56 million following the completion of this transaction.
Also, Ragosa Mark sold 8,879 shares, netting a total of over 205,105 in proceeds. Following the sale of shares at $23.10 each, the insider now holds 23,382 shares.
Before that, Ragosa Mark had added 36,287 shares to its account. In a trade valued at $838,230, the Officer bought Kiniksa Pharmaceuticals International Plc shares for $23.10 each.
As published in their initiating research note from Citigroup on March 13, 2025, Kiniksa Pharmaceuticals International Plc [KNSA] has been a Buy and the price target has been revised to $40. Analysts at Jefferies started covering the stock with ‘”a Buy”‘ outlook in a report released in mid September. As of May 03, 2024, Wells Fargo has initiated its “an Overweight” rating for KNSA. Earlier on June 29, 2020, BofA Securities resumed its rating. Their recommendation was “a Buy” for KNSA stock.
Analyzing KNSA Stock Performance
During the last five days, there has been a surge of approximately 7.45%. Over the course of the year, Kiniksa Pharmaceuticals International Plc shares have jumped approximately 20.37%. Shares of the company reached a 52-week high of $24.31 on 03/20/25 and a 52-week low of $17.82 on 01/13/25. A 50-day SMA is recorded $20.27, while a 200-day SMA reached $22.26.
Support And Resistance Levels for Kiniksa Pharmaceuticals International Plc (KNSA)
According to the 24-hour chart, there is a support level at 23.09, which, if violated, would cause prices to drop to 22.37. In the upper region, resistance lies at 24.42. The next price resistance is at 25.03. RSI (Relative Strength Index) is 71.54 on the 14-day chart, showing overbought technical sentiment. Moving Average Convergence Divergence (MACD) is at 1.09, which suggests the price will increase in the coming days. Percent R is at 12.76%, indicating bullish price movement. Stochastics %K at selling indicates that the stock is to be held.
